Patient-Administered Biologic and Biosimilar Filgrastim May...

  • Main
  • 2018 / 08
  • Patient-Administered Biologic and Biosimilar Filgrastim May...

Patient-Administered Biologic and Biosimilar Filgrastim May Offer More Affordable Options for Patients with Nonmyeloid Malignancies Receiving Chemotherapy in the United States: A Budget Impact Analysis from the Payer Perspective

Trautman, Holly, Szabo, Erika, James, Elizabeth, Tang, Boxiong
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Managed Care & Specialty Pharmacy
DOI:
10.18553/jmcp.2018.18094
Date:
August, 2018
File:
PDF, 222 KB
english, 2018
Conversion to is in progress
Conversion to is failed